Trial of cytostatic therapy of malignant brain tumors in adults
Marek, K.
Schweizer Archiv für Neurologie Neurochirurgie und Psychiatrie 110(1): 27-43
1972
ISSN/ISBN: 0036-7273 PMID: 4337590 Document Number: 54163
Document emailed within 1 workday
Related Documents
Quäck, J. 1973: Cytostatic therapy of malignant tumors from radiological point of view Die Medizinische Welt 24(47): 1845-1848Zwicker, H.; Gürtler, J. 1976: The efficacy of cytostatic therapy for malignant tumors as determined by x-rays Rontgen-Blatter; Zeitschrift für Rontgen-Technik und Medizinisch-Wissenschaftliche Photographie 29(8): 365-373
Tamiya, T.; Ohmoto, T.; Wei, M.X.; Breakfield, X.O.; Chiocca, E.A. 1994: Gene therapy for brain tumors: gene therapy for malignant brain tumors using prodrug-sensitivity genes (series 4) No Shinkei Geka. Neurological Surgery 22(12): 1099-1110
Base, J. 1980: Complex therapy of malignant testicular tumors in adults Sbornik Vedeckych Praci Lekarske Fakulty Karlovy Univerzity V Hradci Kralove. Suppl 23(3): 219-231
Kostron, H. 1987: Therapy of malignant brain tumors Wiener Klinische Wochenschrift 99(11): 366-369
Kochi, M.; Ushio, Y. 1994: Targeting therapy for malignant brain tumors Gan to Kagaku Ryoho. Cancer and ChemoTherapy 21(6): 738-742
Hirschberg, H.; Sørensen, D.R.; Angell-Petersen, E.; Peng, Q.; Tromberg, B.; Sun, C-Ho.; Spetalen, S.; Madsen, S. 2006: Repetitive photodynamic therapy of malignant brain tumors Journal of Environmental Pathology Toxicology and Oncology: Official Organ of the International Society for Environmental Toxicology and Cancer 25(1-2): 261-279
Nagai, M.; Arai, T. 1982: Interferon therapy for malignant brain tumors-present and future No Shinkei Geka. Neurological Surgery 10(5): 463-476
Stepankovskaia, G.K.; Milianovskiĭ, A.I.; Frolova, G.D. 1977: Determination of sensitivity to cytostatic preparations during chemotherapy of malignant tumors Vrachebnoe Delo 2: 109-112
Rob, L.; Svoboda, B.; Robová, H.; Stankusová, H.; Cwiertka, K.; Neumannová, R.; Petera, J.; Koliba, P.; Kudela, M. 2004: Guideline for gynecological malignant tumors--primary complex therapy in operable stages of malignant tumors of uterus cervix Ceska Gynekologie 69(5): 376-383
Král, V.; Hajdúch, M.; Neoral, C.; Klein, J.; Mihál, V.; Orel, M.; Aujeský, R.; Vyslouzil, K.; Cwiertka, K.; Kolek, V.; Nosková, V. 2000: Significance and possibilities of cytostatic treatment of malignant tumors: testing the effects of cytostatics Rozhledy V Chirurgii: Mesicnik Ceskoslovenske Chirurgicke Spolecnosti 79(3): 134-138
Höffken, K.; Schmidt, C.G. 1986: Cytostatic drugs in the therapy of gastrointestinal tumors Medizinische Klinik 81(4): 135-141
Takagaki, M.; Ono, K.; Oda, Y.; Kikuchi, H.; Nemoto, H.; Iwamoto, S.; Cai, J.; Yamamoto, Y. 1996: Hydroxylforms of p-boronophenylalanine as potential boron carriers on boron neutron capture therapy for malignant brain tumors Cancer Research 56(9): 2017-2020
Bunyaratavej, K.; Siwanuwatn, R.; Chantra, K.; Khaoroptham, S. 2010: Duration of symptoms in brain tumors: influencing factors and its value in predicting malignant tumors Journal of the Medical Association of Thailand 93(8): 903-910
Von Gumppenberg, S.; Fink, U.; Lindner, H. 1978: Therapy of malignant bone tumors. Recommendations for the therapy of malignant primary and secondary bone tumors Fortschritte der Medizin 96(31): 1542-1549
Kosteljanetz, M. 2002: Brain tumors. Mainly glial tumors in adults Ugeskrift for Laeger 164(23): 3017-3020
Varmas, K.D.; Schenck, P.; Lange, D. 1971: A study of simultaneous radioactive gold and cytostatic therapy in the treatment of malignant effusions Nuclear-Medizin 10(1): 69-76
Hansen, S.H.; Vetner, M. 1974: Fatal varicella infection in two patients with malignant systemic disease in cytostatic therapy Ugeskrift for Laeger 136(26): 1451
Petru, E.; Beck, K.; Schünemann, H.; Schmähl, D. 1991: The significance of hormone receptor content in primary tumors for cytostatic therapy of advanced breast carcinoma Wiener Medizinische Wochenschrift 141(7): 133-135
Röttinger, E.M. 1995: Survival of children with primitive neuroectodermal tumors and malignant ependymomas of the central nervous system after treatment with 8 cytostatic agents in one day. A report of the Children's Cancer Group Strahlentherapie und Onkologie: Organ der Deutschen Rontgengesellschaft . 171(5): 303-304